Carbenoxolone (disodium) - HY-B1367
Nicht lieferbar
Nur noch %1 verfügbar
Catalog #
HY-B1367
Carbenoxolone disodium is the active metabolite of Glycyrrhizic acid (HY-N0184) and the inhibitor of human 11β-HSD and bacterial 3α, 20β-HSD[1]. Carbenoxolone disodium is an uncoupling agent for gap junctions and a potent inhibitor of Vaccinia virus replication[2]. Carbenoxolone disodium is used for the study of peptic, esophageal and oral ulceration and inflammation. Carbenoxolone disodium inhibits Vaccinia virus replication.
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-B1367/Carbenoxolone-disodium-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | COVID-19-anti-virus |
| CAS | 7421-40-1 |
| Storage | -20°C (Powder, sealed storage, away from moisture) |
| MWT | 614.72 |
| Solubility | DMSO : 12.5 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 50 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | 11β-HSD;Gap Junction Protein;Orthopoxvirus |
| Application: | COVID-19-anti-virus |
|---|